SARS-CoV-2 infection (COVID-19) in children

Since the outbreak in December 2019, the SARS-CoV-2 pandemic virus has been a major public health problem in all countries of the world. The virus is transmitted by inhalation of respiratory droplets from the patient or asymptomatic carrier and is highly contagious. The clinical disease in children is similar to any acute respiratory infection with predominant upper respiratory symptoms, but occasionally can progress to pneumonia with acute respiratory distress syndrome and multiorgan failure. The disease is milder in children than in adults, with low mortality, and it appears that infants and young children have a somewhat more severe clinical course. Diagnosis is made by detecting the virus from respiratory samples (mainly nasopharyngeal and oropharyngeal swabs) using polymerase chain reaction. Treatment is usually symptomatic, and in severe and critical forms, the use of one of the antiviral drugs (lopinavir-ritonavir, remdesivir, hydroxychloroquine) may be considered. Key words: SARSCOV2; COVID19; CHILDREN; THERAPEUTICS
Keywords:
Category: Review
Volume: Vol. 64, No 2, april - june 2020
Authors: Lorna Stemberger Marić, Srđan Roglić
Reference work: Paediatr Croat. 2020;64:94-100
DOI: http://dx.doi.org/10.13112/PC.2020.13

 The whole article is viewable only to subscribers! If you are a subscriber please login.